Blog Business Entertainment Environment Health Latest News News Analysis Opinion Science Sports Technology World
In India, the Novavax Covid Vaccine has been approved for emergency use in children aged 12 to 18

Novavax, a biotechnology company dedicated to developing and commercialising next-generation vaccines for serious infectious diseases, announced on Tuesday the first emergency use authorization of its COVID-19 vaccine for adolescents aged 12 to 18 years in India.

According to a Novovax official statement, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covavax, is the first protein-based vaccine approved for use in this age group in India.

The Drugs Controller General of India (DCGI) has approved Covovax for limited use in an emergency situation for active immunisation against COVID-19 caused by SARS-CoV-2 in people aged 12 and up.

Stanley C Erck, President and CEO of Novavax said that “We are proud of this first approval in adolescents given the efficacy and safety that our data show in this population and our COVID-19 vaccine will provide an alternative protein-based vaccine option for individuals 12 years of age and older in India”.

He further added, “We are proud to offer a protein-based COVID-19 vaccine with a favourable safety profile to our country's adolescents”.

Notably, in December, DCGI (Drugs Controller General Of India) granted emergency use authorization for Covovax for adults aged 18 and up. Furthermore, Covovax has been granted an Emergency Use Listing (EUL) by the World Health Organization, as well as EUA in Indonesia, the Philippines and Bangladesh.

The DCGI has approved Covovax as the fourth vaccine for use in adolescents aged 12 and up. The safety and efficacy of Covovax in adolescents under the age of 12 years have not yet been established; however, studies in India are currently underway to assess the safety and immunogenicity of Covovax in the age groups of 7 to 12 years and 2 to 7 years.

Share This Post On

Tags: #drugs#novavax#India


Leave a comment

You need to login to leave a comment. Log-in
TheSocialTalks was founded in 2020 as an alternative to mainstream media which is fraught with misinformation, disinformation and propaganda. We have a strong dedication to publishing authentic news that abides by the principles and ethics of journalism. We are a not-for-profit organisation driven by a passion for truth and justice in society.

Our team of journalists and editors from all over the world work relentlessly to deliver real stories affecting our society. To keep our operations running, we depend on support in the form of donations. Kindly spare a minute to donate to support our writers and our cause. Your financial support goes a long way in running our operations and publishing real news and stories about issues affecting us. It also helps us to expand our organisation, making our news accessible to more everyone and deepening our impact on the media.

Support fearless and fair journalism today.